Oncothyreon Inc. (ONTY) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 134 transactions totaling $3.3M, demonstrating a bullish sentiment with $2.7M in net insider flow. The most recent transaction on Sep 5, 2015 involved a transaction of 4,336 shares valued at $14.1K.
No significant insider buying has been recorded for ONTY in the recent period.
No significant insider selling has been recorded for ONTY in the recent period.
Based on recent SEC filings, insider sentiment for ONTY is bullish with an Insider Alignment Score of 91/100 and a net flow of $2.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Oncothyreon Inc. (ONTY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading ONTY stock, having executed 134 transactions in the past 90 days. The most active insider is Partners L. P/il Bvf (Executive), who has made 4 transactions totaling $1.8M.
Get notified when executives and directors at ONTY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 5, 2015 | W. Love Ted | Executive | Payment | 4,336 | $3.25 | $14.1K | |
| Sep 5, 2015 | W. Love Ted | Executive | Option Exercise | 17,341 | $N/A | $0 | |
| Jun 13, 2015 | L. Jackson Richard | Executive | Payment | 4,011 | $3.88 | $15.6K | |
| Jun 13, 2015 | L. Jackson Richard | Executive | Option Exercise | 16,042 | $N/A | $0 | |
| Jun 13, 2015 | K. Spiegelman Daniel | Executive | Option Exercise | 16,042 | $N/A | $0 | |
| Jun 13, 2015 | K. Spiegelman Daniel | Executive | Payment | 4,011 | $3.88 | $15.6K | |
| Jun 1, 2015 | Hausman Diana | Executive | Purchase | 5,747 | $4.65 | $26.7K | |
| Mar 26, 2015 | K. Spiegelman Daniel | Executive | Purchase | 10,000 | $1.59 | $15.9K | |
| Mar 26, 2015 | K. Spiegelman Daniel | Executive | Purchase | 10,000 | $1.59 | $15.9K | |
| Mar 25, 2015 | K. Spiegelman Daniel | Executive | Purchase | 10,000 | $1.63 | $16.3K | |
| Mar 25, 2015 | K. Spiegelman Daniel | Executive | Purchase | 10,000 | $1.63 | $16.3K | |
| Feb 5, 2015 | L. P/il Bvf Partners | Executive | Other | 2,600,000 | $N/A | $0 | |
| Feb 5, 2015 | L. P/il Bvf Partners | Executive | Other | 1,400,000 | $N/A | $0 | |
| Dec 17, 2014 | Bvf Inc/il | Executive | Purchase | 55,197 | $1.73 | $95.5K | |
| Dec 17, 2014 | Bvf Inc/il | Executive | Purchase | 98,298 | $1.73 | $170.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 29 | $3.0M | 44.3% |
Other(J) | 15 | $1.8M | 26.7% |
Award(A) | 23 | $650.0K | 9.7% |
Exercise (Options)(X) | 6 | $617.7K | 9.2% |
Payment(F) | 34 | $315.4K | 4.7% |
Sale(S) | 3 | $283.5K | 4.2% |
Disposition(D) | 1 | $79.5K | 1.2% |
Exercise(M) | 23 | $0 | 0.0% |
Insiders at Oncothyreon Inc. are accumulating shares at an accelerated pace. With 23 insiders making 134 transactions totaling $3.0M in purchases versus $283.5K in sales, the net buying activity of $2.7M signals strong executive confidence. Partners L. P/il Bvf (Executive) leads the buying activity with $1.8M in transactions across all time.